Yourgene Health test receives approval from Australian regulators
Novacyt, the French molecular diagnostics company with a growing portfolio of integrated technologies and services including Manchester-based Yourgene Health, has received Australian regulatory approval for its Yourgene Insight DPYD test.
The approval enables Southern Cross Diagnostics Pty, part of the Novacyt Group, to market and supply the in vitro diagnostic assay for its approved clinical diagnostic use in Australia, extending its commercial opportunity beyond research use only to clinical diagnostic testing.
The Therapeutic... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...